戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (left1)

通し番号をクリックするとPubMedの該当ページを表示します
1                                              Overall, 62.1% of eyes had spherical equivalent within +/-0.5 D and 80.9% wi
2      Prior to hospital-diagnosis (median of 32 days), 45.1% of patients had one or more visits with symptoms consistent w
3                    In pre- and post-SLND PET comparison, 10 of 16 had at least one lesion already detected at baseline (6
4 ains infected 29 (41%) patients over five years; 16% (n=14) of infections had mixed-strains.
5                             At the time of elevated VL, 19% of cases had antiretrovirals detected in plasma, compared wit
6 f the cases had a positive history of malignancy, while 19% of them had a positive history of breast cancer in first- or
7 ymph nodes were the most common site of recurrence, and 28% of patients had (11)C-choline-positive suspected recurrences
8                                A total of 75.9% (N=171,287) of patients had any use of benzodiazepines or Z-drugs, and du
9                           After 10 years of follow-up, 3.3% of participants had developed restrictive spirometry pattern.
10 esion already detected at baseline (63% PET persistence), 4 of 16 had new lesions only (25% PET recurrence), and 2 had no
11                        At STAB2, 7.8% of VTE cases and 2.4% of controls had a qualifying rare variant.
12       Ten percent of subjects with the Pi*MZ genotype vs 4% of noncarriers had LSMs of 7.1 kPa or more (adjusted odds rat
13                          Three years postoperatively, 11.4% of patients had an Nd:YAG capsulotomy in the Vivinex XY1 eye
14 septic shock, 346 of 389 subjects (88.9%) were alive and 43 of 389 had died (11.1%); 203 of 389 (52.2%) had completed pai
15 baseline second highest FRI score of 2, between 25% and 44% of participants had follow-up FRI scores each of 0, 1, and 2.
16                                             In phase 1, 50% of recipients had a technically successful uterus transplant,
17 0-364 days), 22 TEAEs were reported by 7 (2.8%) patients, 6 of whom had previously received DEX.
18 rs, at least 25% of cells carried driver mutations and 0-6% of cells had two or even three drivers.
19  underwent 215 US, 167 CT, and 69 MRI examinations, and 67% of them had biopsy-confirmed metastases.
20                    After adjustment, current DMPA users (7% of cohort) had blood lead concentrations that were 18% higher
21                                                    Over 70% of survivors had proteinuria on long-term follow-up.
22            During inpatient follow-up (median 20 days), 77% of patients had a study-related endpoint (death 32%, discharg
23 nstant or age-varying FOI, and the age at which 50% and 80% of children had been infected.
24                                            A majority (80%) of children had bilateral glaucoma and underwent filtering su
25 nd 54.2 (11.2) years among HIV+ participants (P<0.001), 83% of whom had undetectable (<20 copies/mL) HIV-1 viral load (VL
26                                                  Only 0.86% of patients had an HZ-related hospitalization.
27                                                    Addition of vancomycin had minimal impact on CDI rates (data not shown
28                                  While acute administration of fasudil had no impact on seizure activity, seven weeks of
29                                          Sixty-two per cent of participants had phenotypic features that met the diagnost
30                                                 Lower doses of zinc had noninferior efficacy for the treatment of diarrhe
31     Compared to persons without IE, patients with a history of IE had a significantly increased risk of IS; the risk was
32 , compared with control subjects, CHR subjects (independent of outcome) had higher levels of triacylglycerols with a low
33         Accordingly, genetic and pharmacological inhibition of HuR had potent cytostatic and cytotoxic effects on tumor g
34                                               The Institute of Anatomy had 150 body donors in the time period from Januar
35            Viral genome sequencing showed that the majority of HCWs had the dominant lineage B.1.
36                                                    Majority of patients had a durable response to FMT despite exposure to
37                                                  A majority of patients had sustained remissions.
38 ienced drug-free remission after rituximab therapy and none of them had relapse (median follow-up after remission = 3.6 y
39 ree children who initiated ART after 2.3 months of age, one of whom had two identical intact sequences, suggestive of a c
40                                               Fifty percent of patients had a clotting index in the hypercoagulable range
41                                       Seventy-seven percent of patients had adverse events (AEs) during open-label titrat
42  healthy controls, and in both patient groups, a proportion of patients had clearly prolonged or shortened CLTs.
43                                                   A quarter of variants had heritability estimates greater than 10% with
44 le was the use of dental services, based on the self-report of having had a dental visit within the previous year, except
45                                Finally, a genetic signature of autophagy had negative prognostic value in patients with b
46 pancy rate (n = 20,865, 61.6%), whereas only a small subset of patients had an HP procedure at a low occupancy rate hospi
47         Most seropositive children (6/8) were not suspected of having had COVID-19.
48                                            About two-thirds of participants had completed tertiary education.
49  for highly fluctuating precursors, even when the two types of precursors had the same mean level and both activated the
50 sting; in the population screening, no child under 10 years of age had a positive result, as compared with 0.8% of those